Biblio

Export 372 results:
Author Keyword Title Type [ Year(Asc)]
Filters: Keyword is Alzheimer Disease  [Clear All Filters]
2016
T. Nagata, Shinagawa, S., Nakajima, S., Plitman, E., Mihashi, Y., Hayashi, S., Mimura, M., and Nakayama, K., Classification of Neuropsychiatric Symptoms Requiring Antipsychotic Treatment in Patients with Alzheimer's Disease: Analysis of the CATIE-AD Study., J Alzheimers Dis, vol. 50, no. 3, pp. 839-45, 2016.
V. Bonet-Costa, Herranz-Pérez, V., Blanco-Gandía, M. C., Mas-Bargues, C., Inglés, M., Garcia-Tarraga, P., Rodriguez-Arias, M., Miñarro, J., Borras, C., Garcia-Verdugo, J. Manuel, and Viña, J., Clearing Amyloid-β through PPARγ/ApoE Activation by Genistein is a Treatment of Experimental Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 701-11, 2016.
Y. - L. Chang, Yen, Y. - S., Chen, T. - F., Yan, S. - H., and Tseng, W. - Y. Isaac, Clinical Dementia Rating Scale Detects White Matter Changes in Older Adults at Risk for Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 411-23, 2016.
K. Hensley and Kursula, P., Collapsin Response Mediator Protein-2 (CRMP2) is a Plausible Etiological Factor and Potential Therapeutic Target in Alzheimer's Disease: Comparison and Contrast with Microtubule-Associated Protein Tau., J Alzheimers Dis, vol. 53, no. 1, pp. 1-14, 2016.
S. Wong, Bertoux, M., Savage, G., Hodges, J. R., Piguet, O., and Hornberger, M., Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia., J Alzheimers Dis, vol. 51, no. 3, pp. 889-903, 2016.
E. Racine, Forlini, C., Aspler, J., and Chandler, J., Complementary and Alternative Medicine in the Context of Earlier Diagnoses of Alzheimer's Disease: Opening the Conversation to Prepare Ethical Responses., J Alzheimers Dis, vol. 51, no. 1, pp. 1-9, 2016.
X. Sun, Ma, R., Yao, X., Shang, X., Wang, Q., Wang, J. - Z., and Liu, G., Concanavalin agglutinin levels are decreased in peripheral blood of Alzheimer's disease patients., J Alzheimers Dis, vol. 49, no. 1, pp. 63-72, 2016.
O. Turró-Garriga, Garre-Olmo, J., Calvó-Perxas, L., Reñé-Ramírez, R., Gascón-Bayarri, J., and Conde-Sala, J. Lluís, Course and Determinants of Anosognosia in Alzheimer's Disease: A 12-Month Follow-up., J Alzheimers Dis, vol. 51, no. 2, pp. 357-66, 2016.
G. D'Onofrio, Panza, F., Sancarlo, D., Paris, F. F., Cascavilla, L., Mangiacotti, A., Lauriola, M., Paroni, G. H., Seripa, D., and Greco, A., Delusions in Patients with Alzheimer's Disease: A Multidimensional Approach., J Alzheimers Dis, vol. 51, no. 2, pp. 427-37, 2016.
A. Johnen, Frommeyer, J., Modes, F., Wiendl, H., Duning, T., and Lohmann, H., Dementia Apraxia Test (DATE): A Brief Tool to Differentiate Behavioral Variant Frontotemporal Dementia from Alzheimer's Dementia Based on Apraxia Profiles., J Alzheimers Dis, vol. 49, no. 3, pp. 593-605, 2016.
S. Wang, Zhang, Y., Liu, G., Phillips, P., and Yuan, T. - F., Detection of Alzheimer's Disease by Three-Dimensional Displacement Field Estimation in Structural Magnetic Resonance Imaging., J Alzheimers Dis, vol. 50, no. 1, pp. 233-48, 2016.
J. H. Lingler, Butters, M. A., Gentry, A. L., Hu, L., Hunsaker, A. E., Klunk, W. E., Mattos, M. K., Parker, L. A., J Roberts, S., and Schulz, R., Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment., J Alzheimers Dis, vol. 52, no. 1, pp. 17-24, 2016.
V. Boccardi, Ruggiero, C., Patriti, A., and Marano, L., Diagnostic Assessment and Management of Dysphagia in Patients with Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 4, pp. 947-55, 2016.
E. Niemantsverdriet, Goossens, J., Struyfs, H., Martin, J. - J., Goeman, J., De Deyn, P. Paul, Vanderstichele, H., and Engelborghs, S., Diagnostic Impact of Cerebrospinal Fluid Biomarker (Pre-)Analytical Variability in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 1, pp. 97-106, 2016.
O. Bousiges, Cretin, B., Lavaux, T., Philippi, N., Jung, B., Hezard, S., Heitz, C., Demuynck, C., Gabel, A., Martin-Hunyadi, C., and Blanc, F., Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies., J Alzheimers Dis, vol. 51, no. 4, pp. 1069-83, 2016.
S. L. Gardener, Rainey-Smith, S. R., and Martins, R. N., Diet and Inflammation in Alzheimer's Disease and Related Chronic Diseases: A Review., J Alzheimers Dis, vol. 50, no. 2, pp. 301-34, 2016.
B. G. Schreurs and D Sparks, L., Dietary high cholesterol and trace metals in the drinking water increase levels of ABCA1 in the rabbit hippocampus and temporal cortex., J Alzheimers Dis, vol. 49, no. 1, pp. 201-9, 2016.
E. Makovac, Serra, L., Spanò, B., Giulietti, G., Torso, M., Cercignani, M., Caltagirone, C., and Bozzali, M., Different Patterns of Correlation between Grey and White Matter Integrity Account for Behavioral and Psychological Symptoms in Alzheimer's Disease., J Alzheimers Dis, vol. 50, no. 2, pp. 591-604, 2016.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein., J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
A. Dodich, Cerami, C., Crespi, C., Canessa, N., Lettieri, G., Iannaccone, S., Marcone, A., Cappa, S. F., and Cacioppo, J. T., Differential Impairment of Cognitive and Affective Mentalizing Abilities in Neurodegenerative Dementias: Evidence from Behavioral Variant of Frontotemporal Dementia, Alzheimer's Disease, and Mild Cognitive Impairment., J Alzheimers Dis, vol. 50, no. 4, pp. 1011-22, 2016.
N. R. Barthélemy, Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., and Lehmann, S., Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies., J Alzheimers Dis, vol. 51, no. 4, pp. 1033-43, 2016.
N. Bartolotti, Segura, L., and Lazarov, O., Diminished CRE-Induced Plasticity is Linked to Memory Deficits in Familial Alzheimer's Disease Mice., J Alzheimers Dis, vol. 50, no. 2, pp. 477-89, 2016.
M. Bolós, Llorens-Martín, M., Jurado-Arjona, J., Hernández, F., Rábano, A., and Avila, J., Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo., J Alzheimers Dis, vol. 50, no. 1, pp. 77-87, 2016.
M. Lacalle-Aurioles, Navas-Sánchez, F. Javier, Alemán-Gómez, Y., Olazarán, J., Guzmán-De-Villoria, J. Adán, Cruz-Orduña, I., Mateos-Pérez, J. María, and Desco, M., The Disconnection Hypothesis in Alzheimer's Disease Studied Through Multimodal Magnetic Resonance Imaging: Structural, Perfusion, and Diffusion Tensor Imaging., J Alzheimers Dis, vol. 50, no. 4, pp. 1051-64, 2016.
D. Jigar Shah, Rohlfing, F., Anand, S., W Johnson, E., Alvarez, M. H. Tanielle B., Cobell, J., King, J., Young, S. A., Kauwe, J. S. K., and Graves, S. W., Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer's Disease., J Alzheimers Dis, vol. 49, no. 2, pp. 317-27, 2016.

Pages